{
    "2020-03-27": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Spiros Segalas Starts the New Year Adding 5 Stocks to Portfolio",
                "features": {
                    "keywords": [
                        "New Year",
                        "Adding",
                        "Stocks",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Yahoo Finance Presents: Senator Kirsten Gillibrand",
                "features": {
                    "keywords": [
                        "Yahoo Finance",
                        "Senator",
                        "Kirsten Gillibrand"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Bristol Myers (BMY) Clinches FDA Nod for MS Drug Zeposia",
                "features": {
                    "keywords": [
                        "Bristol Myers",
                        "FDA",
                        "Nod",
                        "MS Drug",
                        "Zeposia"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Drugmaker Vertex to delay new clinical studies due to coronavirus",
                "features": {
                    "keywords": [
                        "Drugmaker",
                        "Vertex",
                        "delay",
                        "clinical studies",
                        "coronavirus"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}